{"id":{"repo_id":"duquesne","oai_identifier":"oai:dsc.duq.edu:etd-2550"},"canonical_url":"https://search.ndltd.org/etd/duquesne/oai:dsc.duq.edu:etd-2550","repository":{"repo_id":"duquesne","name":"Duquesne","base_url":"https://dsc.duq.edu/do/oai/"},"display":{"title":"Synthesis of Bicyclic Pyrrolo[2,3-d]Pyrimidines, and Tricyclic Indeno[2,1-d]/[1,2-d]Pyrimidines as Receptor Tyrosine Kinase (RTK) Inhibitors and Antimitotic Agents","abstract":"The dissertation will give an introduction, background and our research progress in the areas of receptor tyrosine kinases inhibitors and antimitosis inhibitors. The design and syntheses of bicyclic pyrrolo[2,3-d]pyrimidines, and tricyclic indeno[2,1-d]- and [1,2-d]pyrimidines as receptor tyrosine kinase inhibitors and bicyclic pyrrolo[2,3-d]pyrimidines, and tricyclic indeno[2,1-d]pyrimidines as antimitotic inhibitors have been described. As a part of this study, a total of two hundred and eleven new compounds have been synthesized and characterized. Of these, ninety five final compounds were submitted for biological evaluation.","abstract_html":"The dissertation will give an introduction, background and our research progress in the areas of receptor tyrosine kinases inhibitors and antimitosis inhibitors. The design and syntheses of bicyclic pyrrolo[2,3-d]pyrimidines, and tricyclic indeno[2,1-d]- and [1,2-d]pyrimidines as receptor tyrosine kinase inhibitors and bicyclic pyrrolo[2,3-d]pyrimidines, and tricyclic indeno[2,1-d]pyrimidines as antimitotic inhibitors have been described. As a part of this study, a total of two hundred and eleven new compounds have been synthesized and characterized. Of these, ninety five final compounds were submitted for biological evaluation.","abstract_has_math":false,"creators":["Zhao, Ying"],"institution":null,"degree_name":"PhD","degree_level":"Immediate Access","degree_discipline":"Medicinal Chemistry","degree_department":null,"school":null,"contributors":["Aleem Gangjee","Marc W Harrold","Patrick T Flaherty","David J Lapinsky","Moji C Adeyeye","J. Douglas Bricker","David A Johnson"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T07:52:32Z","subjects":["antimitotic","cancer","inhibitor","mincrotubulin","receptor tyrosin kinase"],"languages":["English"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://dsc.duq.edu/etd/1538","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://dsc.duq.edu/etd/1538","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://dsc.duq.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adsc.duq.edu%3Aetd-2550","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Aleem Gangjee","Marc W Harrold","Patrick T Flaherty","David J Lapinsky","Moji C Adeyeye","J. Douglas Bricker","David A Johnson"]},{"key":"dc:creator","label":"Author","values":["Zhao, Ying"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2023-01-05T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2010-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medicinal Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Immediate Access"]},{"key":"thesis:degree_name","label":"Degree Name","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["antimitotic","cancer","inhibitor","mincrotubulin","receptor tyrosin kinase"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dsc.duq.edu/etd/1538"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The dissertation will give an introduction, background and our research progress in the areas of receptor tyrosine kinases inhibitors and antimitosis inhibitors. The design and syntheses of bicyclic pyrrolo[2,3-d]pyrimidines, and tricyclic indeno[2,1-d]- and [1,2-d]pyrimidines as receptor tyrosine kinase inhibitors and bicyclic pyrrolo[2,3-d]pyrimidines, and tricyclic indeno[2,1-d]pyrimidines as antimitotic inhibitors have been described. As a part of this study, a total of two hundred and eleven new compounds have been synthesized and characterized. Of these, ninety five final compounds were submitted for biological evaluation."]},{"key":"dc:title","label":"Title","values":["Synthesis of Bicyclic Pyrrolo[2,3-d]Pyrimidines, and Tricyclic Indeno[2,1-d]/[1,2-d]Pyrimidines as Receptor Tyrosine Kinase (RTK) Inhibitors and Antimitotic Agents"]}]}],"canonical_facts":{"dc:contributor":["Aleem Gangjee","Marc W Harrold","Patrick T Flaherty","David J Lapinsky","Moji C Adeyeye","J. Douglas Bricker","David A Johnson"],"dc:creator":["Zhao, Ying"],"dc:date.available":["2023-01-05T08:00:00Z"],"dc:date.created":["2010-01-01T08:00:00Z"],"dc:description.abstract":["The dissertation will give an introduction, background and our research progress in the areas of receptor tyrosine kinases inhibitors and antimitosis inhibitors. The design and syntheses of bicyclic pyrrolo[2,3-d]pyrimidines, and tricyclic indeno[2,1-d]- and [1,2-d]pyrimidines as receptor tyrosine kinase inhibitors and bicyclic pyrrolo[2,3-d]pyrimidines, and tricyclic indeno[2,1-d]pyrimidines as antimitotic inhibitors have been described. As a part of this study, a total of two hundred and eleven new compounds have been synthesized and characterized. Of these, ninety five final compounds were submitted for biological evaluation."],"dc:identifier":["https://dsc.duq.edu/etd/1538"],"dc:language":["English"],"dc:subject":["antimitotic","cancer","inhibitor","mincrotubulin","receptor tyrosin kinase"],"dc:title":["Synthesis of Bicyclic Pyrrolo[2,3-d]Pyrimidines, and Tricyclic Indeno[2,1-d]/[1,2-d]Pyrimidines as Receptor Tyrosine Kinase (RTK) Inhibitors and Antimitotic Agents"],"thesis:degree_discipline":["Medicinal Chemistry"],"thesis:degree_level":["Immediate Access"],"thesis:degree_name":["PhD"]},"updated_at":"2026-11-19T07:52:32Z"}